Skip to content
High Tech Series D Founded 2011

Leon-nanodrugs

Leon-nanodrugs is a developer of technology for manufacturing lipid and polymeric nanoparticles for therapeutics. The companys systems support process development and GMP production of nanoparticles, engineering technology that aims to redefine precision and performance in nanoparticle production. Leon-nanodrugs empowers partners to accelerate the development of next-generation therapeutics by providing scalable,…

📍 Munich, Germany · Nanotechnology,

Funding snapshot

Last roundSeries D
Amount$20M
Date6 August 2024
Total raised$20M
Team size20

About

Leon-nanodrugs is a developer of technology for manufacturing lipid and polymeric nanoparticles for therapeutics. The companys systems support process development and GMP production of nanoparticles, engineering technology that aims to redefine precision and performance in nanoparticle production. Leon-nanodrugs empowers partners to accelerate the development of next-generation therapeutics by providing scalable, reproducible manufacturing solutions for nanoparticle-based drug delivery systems, which are critical for mRNA vaccines, gene therapies, and targeted drug delivery. Founded in 2011 and headquartered in Munich, Germany, Leon-nanodrugs has raised approximately 20.3 million at the Series D stage with investors including Evotec, BayBG Venture Capital, TVM Capital, Signet Healthcare Partners, LifeCare Partners, LBBW Venture Capital, and Albany Capital.

Business model

Nanotechnology > Nanostructures > Diversified,

Drug Delivery > Diversified

Institutional investors

Eckenstein-Geigy-Foundation CD-Venture Evotec BayBG Venture Capital TVM Capital Signet Healthcare Partners LifeCare Partners LBBW Venture Capital Albany Capital

Latest coverage

No articles yet.

Raising like Leon-nanodrugs?

Analyze your pitch deck before your next raise.

Analyze My Deck →